Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Glucagon-like Peptide-1”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT05694741
What this trial is testing

Assess Safety, Tolerability, and Pharmacokinetics of AZD0186

Who this might be right for
Type 2 Diabetes
AstraZeneca 31
Not applicableStudy completedNCT06789263
What this trial is testing

Effect of a Collagen Hydrolysate on Postprandial Blood Glucose Profile, Gastric Emptying and GLP-1 Release in Normoglycemic and Prediabetic Subjects

Who this might be right for
PrediabetesNormoglycemic
Rousselot BVBA 30
Not applicableUnknownNCT06182852
What this trial is testing

The Effect of GLP-1 Receptor Agonist on Bone Metabolism in Patients With Diabetes Mellitus

Who this might be right for
Diabete Type 2Bone Metabolism
Nanjing First Hospital, Nanjing Medical University 330
Large-scale testing (Phase 3)Study completedNCT05290506
What this trial is testing

Linagliptin Response to OGTT in Prediabetes and Type 2 Diabetes Mellitus

Who this might be right for
PreDiabetesType 2 Diabetes
National University of Malaysia 50
Not applicableNot Yet RecruitingNCT07340112
What this trial is testing

Expression of GLP1 Receptor on Peripheral Blood Mononuclear Cells in Advanced Peripheral Artery Disease: Paving the Way for GLP1R Agonists Treatment in Chronic Limb Threatening Ischemia

Who this might be right for
Peripheral Arterial Disease (PAD)Claudication, IntermittentChronic Limb-Threatening Ischemia
University Hospital, Strasbourg, France 50
Large-scale testing (Phase 3)Not Yet RecruitingNCT07797036
What this trial is testing

Postpartum Semaglutide to Reduce Cardiometabolic Risk After Gestational Diabetes Mellitus

Who this might be right for
Gestational Diabetes Mellitus (GDM)Metabolic Syndrome
University of Massachusetts, Worcester 226
Not applicableStudy completedNCT05889637
What this trial is testing

Gastric Ultrasound Assessment for Preoperative Prandial State of Patients Taking Glucagon-Like Peptide-1 Receptor Agonists

Who this might be right for
Pulmonary Aspiration
The University of Texas Health Science Center, Houston 132
Not applicableNot Yet RecruitingNCT07089732
What this trial is testing

Effects of a GLP-1 Formula Drink on Gut Microbiota and Glycemic Control in Prediabetic Individuals

Who this might be right for
ObesityPrediabetes
Chung Shan Medical University 100
Not applicableStudy completedNCT02665715
What this trial is testing

Can Postprandial Reactive Hypoglycaemia be Reduced in Patients After Roux-en-Y Gastric Bypass With a Low Carbohydrate Diet?

Who this might be right for
Bariatric Surgery (Gastric Bypass)
Amirsalar Samkani 10
Not applicableStudy completedNCT01173978
What this trial is testing

Insulinotropic Effect of GIP and GLP-1 Before and After Reduced Glucose Tolerance

Who this might be right for
Insulin ResistanceDeteriorated Glucose HomeostasisInactivity
Glostrup University Hospital, Copenhagen 10
Post-approval studies (Phase 4)Study completedNCT01147276
What this trial is testing

Vildagliptin and the Glucagon Response to Hypoglycemia in Type 1 Diabetes

Who this might be right for
DiabetesHypoglycemia
Lund University 28
Not applicableStudy completedNCT01043445
What this trial is testing

-Oleoyl Glycerol is a GPR119 Agonist and Signals GLP-1 Release in Humans.

Who this might be right for
Type 2 Diabetes
Glostrup University Hospital, Copenhagen 8
Testing effectiveness (Phase 2)Study completedNCT03204396
What this trial is testing

Smoking Cessation Facilitated by Glucagon-like Peptide-1 (GLP-1) Analogues

Who this might be right for
Glucagon-like Peptide-1Smoking CessationWeight Change, Body+1 more
University Hospital, Basel, Switzerland 256
Post-approval studies (Phase 4)Not Yet RecruitingNCT07027969
What this trial is testing

Metabolic Surgery for Atrial Fibrillation Elimination

Who this might be right for
Atrial FibrillationObesity and Obesity-related Medical Conditions
Ali Aminian 100
Not applicableStudy completedNCT06333496
What this trial is testing

Effect of a Glucagon Like Peptide 1 (GLP1) Booster in Healthy Humans

Who this might be right for
Blood Sugar; HighOverweight and ObesityFat Burn+2 more
Alpine Biotech LLC 12
Post-approval studies (Phase 4)Looking for participantsNCT06671587
What this trial is testing

IGlarLixi CGM Study in Chinese T2D Individuals After OADs

Who this might be right for
Type 2 Diabetes (T2D)
Sanofi 678
Large-scale testing (Phase 3)Study completedNCT03987919
What this trial is testing

Tirzepatide (LY3298176) Versus Semaglutide Once Weekly as Add-on Therapy to Metformin in Participants With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes
Eli Lilly and Company 1,879
Not applicableEnrolling By InvitationNCT07687589
What this trial is testing

The Antiemetic Effects of Increased Splanchnic Perfusion, Induced by the Gut Hormone GIP, in Healthy Individuals

Who this might be right for
Emesis
University of Copenhagen 14
Testing effectiveness (Phase 2)Looking for participantsNCT06411210
What this trial is testing

Obesity Complicating Type 1 Diabetes: GLP-1 Analogue Anti-obesity Treatment

Who this might be right for
Diabetes type1Obesity
Yale University 54
Testing effectiveness (Phase 2)Active Not RecruitingNCT07505303
What this trial is testing

MIST (Metabolic Intervention With Semaglutide and THR-β Therapy) Trial

Who this might be right for
Adult ObesityWeight Management
Eccogene 151
Next Page